NHS Northern Ireland - South Eastern Health & Social Care Trust and Glaxo SmithKline UK (GSK)
Working Jointly to Improve Urology Healthcare Executive Summary
To improve quality and productivity in the management of patients with LUTS/BPH in the primary care setting in South Eastern Health & Social Care Trust catchment area
It is anticipated that implementing this training initiative will realise the following benefits to patients, GPs, SEHSC Trust and GSK:
- Up-skill knowledgeable local GPs to a higher level of expertise in urology LUTS management.
- Enhanced alignment of patient care and prescribing in line with the recommendations, including drug treatment recommendations, described in the NICE Clinical Guideline 97: ‘The management of lower urinary tract symptoms in men’.
Both parties have committed resources to support this project which will run from February 2012 - June 2013.
In 2009 a ‘Review of Adult Urology Services in Northern Ireland’ was commissioned. The Review concluded that reform is necessary.
Areas of concern highlighted were:
1. the need to introduce a new model of service delivery which is fit for purpose
2. workforce planning, training and development needs
3. future resourcing, provided in the right place at the right time by appropriately trained and skilled staff
“Aim: to ensure greater engagement between secondary and primary care clinicians and practitioners to agree clinical pathways which reduce the use of hospital services and increase the capability of primary care to manage patients more locally”
In consultation with clinical experts from the Trust, it was agreed that GSK and SEHSCT would develop a training initiative that promoted enhanced understanding and confidence to manage LUTS within general practice. This has the potential to translate in to clinical benefits for patients as a result of earlier diagnosis/appropriate interventions, as well as realising rational prescribing benefits to both the practice and Trust if patients are optimally medicated earlier in the disease progression. There is also likely to be a reduction in referrals to secondary care, and a decrease in acute hospital admissions for AUR and/or BPH related surgery.
The associated audit capability will be contracted to an external agency, Quintiles, which has the requisite expertise and credentials. Qualified Quintiles ‘Healthcare Information Technology Systems’ (HITS) personnel will ensure that all patient data collected will be anonymised, and amalgamated at practice level, to safeguard patient confidentiality at all times.
It has been agreed that GSK UK and South Eastern Health & Social Care Trust will work together through the Joint Working Project ‘Urology Steering Group’, and will combine financial and people resource in this Joint Working Project.
For further information contact:
GSK UK Customer Contact Centre: +44 (0)800 221 441
1. NICE Clinical Guideline 97 ‘The management of lower urinary tract symptoms in men’ (Accessed April 2013)
UK/URO/0185b/11(1) Archived 2015.